Previous 10 | Next 10 |
--News Direct-- The Trotwood-Madison school district is implementing the GBM curriculum for Westbrooke fifth graders at no cost thanks to a grant partnership between GBM and Quest Diagnostics Foundation of New Jersey. “Quest Foundation, in conjunction with Quest for Health Eq...
Physicians Foresee an Alzheimer's Disease Treatment Revolution Supported by Advanced Testing Tools, New Quest Diagnostics Report Finds PR Newswire Blood Test for Early Detection of Alzheimer's Disease (AD) Risk Will Lead to Better Patient Care, Physicians Say; U.S. Adult...
--News Direct-- Quest honors the dedication of all lab professionals providing essential insights that are vital to healthcare decisions. This #LabWeek, we’re grateful for all you do to help move our country forward. Providing certainty in an uncertain world There...
Quest Diagnostics Incorporated (DGX) Q1 2022 Earnings Conference Call April 21, 2022 8:30 A.M. ET Company Participants Shawn Bevec - Vice President, Investor Relations Steve Rusckowski - Chairman and Chief Executive Officer and President Jim Davis - Chief Executive Officer-Elect Mark Guinan -...
Quest Diagnostics (NYSE:DGX) reported mixed Q1 results but raised its FY22 EPS outlook. Q1 net revenue declined -4% Y/Y to $2.61B and missed analysts' estimates. COVID-19 testing revenues decreased -27.66% Y/Y to $599M. "COVID-19 volumes remained strong early in the quarter and decreased in F...
Quest Diagnostics press release (NYSE:DGX): Q1 Non-GAAP EPS of $3.22 beats by $0.22. Revenue of $2.61B (-4.0% Y/Y) misses by $30M. Base business revenues of $2.01 billion, up 6.3% from 2021 Full year 2022 reported diluted EPS now expected to be between $7.88 and $8.38; and adjusted diluted EP...
Quest Diagnostics Reports First Quarter 2022 Financial Results; Raises Guidance for Full Year 2022 PR Newswire First quarter revenues of $2.61 billion , down 4.0% from 2021 First quarter reported diluted earnings per share ("EPS") of $2.92 , down 15.6% from...
Quest Diagnostics Announces Organizational Changes to Accelerate Growth and Drive Operational Excellence PR Newswire SECAUCUS, N.J. , April 20, 2022 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic informat...
Quest Diagnostics (NYSE:DGX) is scheduled to announce Q1 earnings results on Thursday, April 21st, before market open. The consensus EPS Estimate is $3.00 (-20.2% Y/Y) and the consensus Revenue Estimate is $2.64B (-2.9% Y/Y). Over the last 2 years, DGX has beaten EPS estimates 100% of the tim...
While the end of the pandemic and possible slowing of the economy may bring inflation down somewhat, we cannot avoid the ramifications tied to years of quantitative easing, rapid money supply growth, and unprecedented fiscal expansion. Virtually every time inflation spiked over the pa...
News, Short Squeeze, Breakout and More Instantly...
Quest Diagnostics Incorporated Company Name:
DGX Stock Symbol:
NYSE Market:
Quest Diagnostics Incorporated Website:
Quest Diagnostics Named a "Best Place to Work for Disability Inclusion" for Seventh Straight Year PR Newswire Quest achieves top score of 100 on 2024 Disability Equality Index® Best Places to Work for Disability Inclusion SECAUCUS, N.J. , Aug. 1, 20...
NORTHAMPTON, MA / ACCESSWIRE / July 30, 2024 / Bread of Life Academy, a program under nonprofit Bread of Life Inc. -a Quest for Health Equity (Q4HE) grantee-recently held a graduation ceremony to celebrate a graduating class of 40 students pursuing careers as phlebotomists and community health ...
Haystack Oncology and Université de Montréal's affiliated hospital research centre, the CRCHUM, to Deploy Haystack MRD™ Technology in Research Study for Metastatic Colorectal Cancer PR Newswire BALTIMORE, Md. and MONTREAL , July 29, 2024 /PRN...